NeurAxis, Inc. (NRXS)
6.21
+0.10
(+1.64%)
USD |
NYAM |
Nov 06, 10:07
NeurAxis Debt to Equity Ratio : 0.0415 for June 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0415 |
| March 31, 2026 | 0.0615 |
| December 31, 2025 | 0.1226 |
| September 30, 2025 | 0.2094 |
| June 30, 2025 | 0.0965 |
| March 31, 2025 | 1.504 |
| December 31, 2024 | 0.229 |
| September 30, 2024 | -0.266 |
| June 30, 2024 | -0.9724 |
| Date | Value |
|---|---|
| March 31, 2024 | -0.5484 |
| December 31, 2023 | -0.1598 |
| September 30, 2023 | -0.2627 |
| June 30, 2023 | -0.1659 |
| March 31, 2023 | -0.0881 |
| December 31, 2022 | -0.1074 |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | -0.532 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Abbott Laboratories | 0.6106 |
| AngioDynamics, Inc. | 0.0655 |
| Alphatec Holdings, Inc. | 27.88 |
| AtriCure, Inc. | 0.1816 |
| Baxter International, Inc. | 1.232 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 9.996M |
| Total Liabilities (Quarterly) | 3.261M |
| Shareholders Equity (Quarterly) | 6.735M |
| Current Ratio | 3.040 |
| Net Debt Paydown Yield | 0.02% |